Inhibikase posts corporate presentation; no specific financial or clinical data in filing

Inhibikase Therapeutics, Inc.

Presentation made available on company website on Aug 15, 2022, for investor presentations.
Filing includes only cover page and disclaimer; full slide deck not reproduced in the 8-K.
Presentation is dated 3Q 2022 and focuses on neurodegenerative disease and cancer therapeutics.
No new financial results, guidance, or clinical milestones were disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.